Hu, Kejia
Wang, Chengshi
Luo, Chuanxu
Zheng, Hong
Song, Huan
Bergstedt, Jacob
Fall, Katja
Luo, Ting
Czene, Kamila
Valdimarsdóttir, Unnur A.
Fang, Fang
Lu, Donghao
Funding for this research was provided by:
China Scholarship Council (201806240005)
Cancerfonden (20 0846 PjF)
National Natural Science Foundation of China (8187111500)
Vetenskapsrådet (2018-00648)
Karolinska Institute
Article History
Received: 11 February 2022
Accepted: 15 June 2022
First Online: 21 June 2022
Declarations
:
: This study was approved by the West China Hospital of Sichuan University Biomedical Research Ethics Committee (No. 2019-16) and the Regional Ethics Review Board in Stockholm, Sweden (Dnr 2020-04828). In the WCH cohort, written informed consent has been obtained from each participant. All patients in TCGA provided informed consent based on the guidelines from the TCGA Ethics, Law and Policy Group. All procedures performed involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The authors declare that they have no competing interests.